DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ inched 0.61% higher to $410.65 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.07% to 43,325.80 and the S&P 500 Index falling 0.04% to 6,037.59.
This was the stock's fourth consecutive day of gains.
Vertex Pharmaceuticals Inc. closed $109.23 below its 52-week high ($519.88), which the company achieved on November 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Thursday, as AbbVie Inc. $(ABBV)$ fell 0.44% to $179.20, Krystal Biotech Inc. (KRYS) rose 1.24% to $160.49, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ rose 2.42% to $16.93.
Trading volume (1.2 M) remained 326,561 below its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled December 26, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
December 26, 2024 16:42 ET (21:42 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments